Brief: Todos Medical Announces Positive Data In Hospitalized And Outpatient Setting For Tollotest, A Novel SARS-CoV-2 3CL Protease Biomarker Assay
06/10/2021 16:26
Oct 6 (Reuters) - Todos Medical Ltd TOMDF.PK :
* TODOS MEDICAL ANNOUNCES POSITIVE DATA IN HOSPITALIZED AND
OUTPATIENT SETTING FOR TOLLOTEST™, A NOVEL SARS-COV-2 3CL
PROTEASE BIOMARKER ASSAY
* TODOS MEDICAL LTD - DATA DEMONSTRATED VERY HIGH
CORRELATION WITH
PCR CT VALUES IN POSITIVE PATIENTS
* TODOS MEDICAL - DATA DEMONSTRATED 100% SENSITIVITY, IN
IDENTIFYING FULLY VACCINATED ASYMPTOMATIC PATIENTS INFECTED WITH
COVID-19
Source text for Eikon: ID:nGNX7Pfnzx
Further company coverage: TOMDF.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Todos Medical
See all newsBrief: Todos Medical Enters Into Exclusive Worldwide Automated Retail Supply Agreement With Smart Automated Retail Network
Brief: Todos Medical Clia/Cap Lab Provista Submits Emergency Use Authorization Application For Monkeypox Pcr Test To Us FDA
Brief: Todos Medical Provides Corporate Update
Brief: Todos Medical Enters Into $50 Mln Contract To Supply Tollovid, CBD Products To Retail Distributor Company Nerd Hemp
Brief: Todos Medical Establishes Botanical Supplement Manufacturing Capabilities